prac

Explore academic connections and research related to this keyword

108
Views
2
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.
Ali, Sahra;Moreau, Alexandre;Melchiorri, Daniela;Camarero, Jorge;Josephson, Filip;Olimpier, Odoardo;...
2020 the oncologist DOI: 10.1634/theoncologis... 171 views

Related Journals

the oncologist
ISSN: 1549-490X 530 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

minimal residual disease acute lymphoblastic leukemia ema chmp comp hematopoietic stem cell transplant